Zobrazeno 1 - 10
of 405
pro vyhledávání: '"An Verrijken"'
Autor:
Evelien Van Dijck, Sara Diels, Erik Fransen, Tycho Canter Cremers, An Verrijken, Eveline Dirinck, Alexander Hoischen, Geert Vandeweyer, Wim Vanden Berghe, Luc Van Gaal, Sven Francque, Wim Van Hul
Publikováno v:
Antioxidants, Vol 13, Iss 9, p 1051 (2024)
The paraoxonase (PON) gene family (including PON1, PON2, and PON3), is known for its anti-oxidative and anti-inflammatory properties, protecting against metabolic diseases such as obesity and metabolic dysfunction-associated steatotic liver disease (
Externí odkaz:
https://doaj.org/article/3610f4d5206345fe9f8499759c900757
Autor:
Guillaume Grzych, Oscar Chávez-Talavera, Amandine Descat, Dorothée Thuillier, An Verrijken, Mostafa Kouach, Vanessa Legry, Hélène Verkindt, Violeta Raverdy, Benjamin Legendre, Robert Caiazzo, Luc Van Gaal, Jean-Francois Goossens, Réjane Paumelle, Sven Francque, François Pattou, Joel T. Haas, Anne Tailleux, Bart Staels
Publikováno v:
JHEP Reports, Vol 3, Iss 2, Pp 100222- (2021)
Background & Aims: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabete
Externí odkaz:
https://doaj.org/article/86f4e08dfca4419c8dc1e4b25ab23c55
Autor:
Sara Diels, Sander Huybreghts, Kim Van Hoorenbeeck, Guy Massa, An Verrijken, Stijn L. Verhulst, Luc F. Van Gaal, Wim Van Hul
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 25, Iss , Pp 100656- (2020)
Genome-wide copy number surveys associated chromosome 11q11 with obesity. As this is an olfactory receptor-rich region, we hypothesize that genetic variation in olfactory receptor genes might be implicated in the pathogenesis of obesity. Multiplex Am
Externí odkaz:
https://doaj.org/article/b49b7fab0d3d4189954827a4d3cd3bb6
Autor:
Abraham S. Meijnikman, Christophe E. M. De Block, An Verrijken, Ilse Mertens, Luc F. Van Gaal
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 10, Iss 1, Pp 1-6 (2018)
Abstract Background The aim of this study to compare the diagnostic accuracy of the metabolic syndrome (MetS) with the FINDRISC score to screen for type 2 diabetes mellitus T2DM in an overweight/obese population. Methods Subjects 18 years or older vi
Externí odkaz:
https://doaj.org/article/f93a50b7761a4f46a30d42512a7c89e6
Autor:
Wim Verlinden, Eugénie Van Mieghem, Laura Depauw, Thomas Vanwolleghem, Luisa Vonghia, Jonas Weyler, Ann Driessen, Dirk Callens, Laurence Roosens, Eveline Dirinck, An Verrijken, Luc Van Gaal, Sven Francque
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 546 (2020)
The incidence of non-alcoholic fatty liver disease (NAFLD) is rising across the globe, with the presence of steatohepatitis leading to a more aggressive clinical course. Currently, the diagnosis of non-alcoholic steatohepatitis (NASH) is based on his
Externí odkaz:
https://doaj.org/article/05ac3ce96c48437f99bd6ec6e195f348
Autor:
Kaat Kehoe, Heidi Noels, Wendy Theelen, Emilie De Hert, Shenguan Xu, An Verrijken, Thierry Arnould, Erik Fransen, Nina Hermans, Anne-Marie Lambeir, Per Venge, Luc Van Gaal, Ingrid De Meester
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197603 (2018)
BACKGROUND:Prolyl carboxypeptidase (PRCP) is involved in the regulation of body weight, likely by hydrolysing alpha-melanocyte-stimulating hormone and apelin in the hypothalamus and in the periphery. A link between PRCP protein concentrations in plas
Externí odkaz:
https://doaj.org/article/2dd0dc721c3b40a0b8ef9ddacedea1a4
Autor:
Johannie du Plessis, Hannelie Korf, Jos van Pelt, Petra Windmolders, Ingrid Vander Elst, An Verrijken, Guy Hubens, Luc Van Gaal, David Cassiman, Frederik Nevens, Sven Francque, Schalk van der Merwe
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0166048 (2016)
Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the development of obesity, insulin resistance and non-alcoholic steatohepatitis (NASH). In order to determine if LPS levels are elevated in patients with NASH
Externí odkaz:
https://doaj.org/article/09ae9032fcc841519ef5a4b7cac0408d
Autor:
Luisa Vonghia, Thea Magrone, An Verrijken, Peter Michielsen, Luc Van Gaal, Emilio Jirillo, Sven Francque
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0143380 (2015)
Haemodynamic impairment, inflammatory mediators and glucose metabolism disturbances have been implicated in the pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD).To investigate the cytokine profile in NAFLD patients in peripheral (P) and hepa
Externí odkaz:
https://doaj.org/article/9de71adf7c234007ad8552db186fa6e2
Autor:
Giovanni Musso, Roberto Gambino, James H Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar Stefan Björnsson, Matthew J Armstrong, Laurence J Hopkins, Xin Gao, Sven Francque, An Verrijken, Yusuf Yilmaz, Keith D Lindor, Michael Charlton, Robin Haring, Markus M Lerch, Rainer Rettig, Henry Völzke, Seungho Ryu, Guolin Li, Linda L Wong, Mariana Machado, Helena Cortez-Pinto, Kohichiroh Yasui, Maurizio Cassader
Publikováno v:
PLoS Medicine, Vol 11, Iss 7, p e1001680 (2014)
BackgroundChronic kidney disease (CKD) is a frequent, under-recognized condition and a risk factor for renal failure and cardiovascular disease. Increasing evidence connects non-alcoholic fatty liver disease (NAFLD) to CKD. We conducted a meta-analys
Externí odkaz:
https://doaj.org/article/3fdb5f1914e441bd9e84c0b5170f460b
Autor:
Margot Berings, Charline Wehlou, An Verrijken, Ellen Deschepper, Ilse Mertens, Jean-Marc Kaufman, Luc F Van Gaal, D Margriet Ouwens, Johannes B Ruige
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45145 (2012)
CONTEXT: Lipotoxicity is a risk factor for developing obesity-related metabolic complications, including non-alcoholic fatty liver disease, type 2 diabetes (DM2), cardiovascular disease and stroke. Yet, the mechanisms underlying the development of li
Externí odkaz:
https://doaj.org/article/d56facb12d0448999eac3ec74622373f